CALA - Calithera Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
22,254
25,955
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
74,564
66,195
43,111
27,748
23,748
Selling General and Administrative
14,482
13,340
12,530
10,586
9,071
Total Operating Expenses
89,046
79,535
55,641
38,334
32,819
Operating Income or Loss
-89,046
-57,281
-29,686
-38,334
-32,819
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
0
0
Income Before Tax
-86,187
-54,629
-27,826
-38,004
-32,644
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-86,187
-54,629
-27,826
-38,004
-32,644
Net Income
-86,187
-54,629
-27,826
-38,004
-32,644
Net Income available to common shareholders
-86,187
-54,629
-27,826
-38,004
-32,644
Reported EPS
Basic
-
-1.49
-0.84
-1.95
-1.81
Diluted
-
-1.49
-0.84
-1.95
-1.81
Weighted average shares outstanding
Basic
-
36,604
32,951
19,486
18,045
Diluted
-
36,604
32,951
19,486
18,045
EBITDA
-
-57,281
-29,686
-38,334
-32,819